Aggregated News

Over the past month, a controversy erupted involving a stem cell company called Celltex Therapeutics and a newly hired executive, Glenn McGee. The issue centered on the confusing circumstances in which he was listed as the editor-in-chief of a bioethics journal at the same time that he began his job at Celltex, which has ties to a controversial stem cell company in South Korea called RNL Bio (see this).

Celltex Therapeutics - which was co-founded by Stan Jones, the same surgeon who treated Texas Governor Rick Perry for back pain with unapproved adult stem cells - has a partnership deal with RNL Bio. And RNL Bio, which has marketed its stem cell treatments in various countries, made headlines nearly two years ago after patient deaths were reported in China and Japan. The International Cellular Medicine Society conducted a review, co-headed by McGee, which largely exonerated RNL.

This thorny episode, which prompted McGee to resign from Celltex (look here), was chronicled by a pair of bioethics professors at the University of Minnesota, both of whom have now...